Special Update: Our Most Recent Live Q&A Replay Is Here
The Canadian investing team took to
Zoom(NASDAQ:ZM) once again this week and were overwhelmed by the audience. Literally. We filled the seat capacity that we didn’t even know existed. As we’ve indicated elsewhere, we’re relatively new to this broadcast game and there’s a learning curve involved. Next time around, there will be plenty of room for all.
In the meantime, the recording has been turned around by the production team, transcript and all, and we’re pleased to share the proceedings as they were.
Our Most Recent Live Chat Replay Is Here!
The Canadian investing team took to
Zoom (NASDAQ:ZM) once again on April 30 for another live Q&A chat. The recording has been turned around by the production team, transcript and all, and we’re pleased to share the replay now.
Miss this event and want to attend the next? Stay tuned for an announcement of our next chat – and mark your calendar accordingly.
Enjoy!
Taylor:
All right. Looks like some fools are starting to filter in. Welcome to our Thursday April 30th edition of our all teams Q and A for our analyst team, from Stock Advisor Canada, Dividend Investor Canada and Hidden Gems Canada. I’m Taylor Muckerman and you know the players here. Bryan, Iain, Joey and Jim. Happy to have you all here again. We see we’re closing in on 200 attendees and just like the last few of these recordings, this is an open Q and A so be sure to put your questions in there and we’ll try to get to as many of them as we can possibly do. Again,
Interview with Rene Geohrum, the Chairman and CEO of BioSyent
Run time – 21:34 (Transcript below)
David Kretzmann: David Kretzmann here with
Hidden Gems Canada. I’m joined today by a very special guest, Rene Geohrum, the chairman and CEO of
Hidden Gems Canada recommendation BioSyent.
Rene, thanks so much for taking the time to talk to the Fool today. I figure we can jump right into it and you can walk you us through what led you to join BioSyent?
Rene Goehrum: Thanks for the invitation, David. My association with BioSyent started a number of years ago as an investor. We were actually known by a different name and we were in a different business. We were in the agtech business. I came as an investor to the company originally.